NKIRAS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.954200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.891400E-01
Normal-vs-Stage2
5.563400E-01
Normal-vs-Stage3
7.995800E-01
Normal-vs-Stage4
1.522780E-01
Stage1-vs-Stage2
3.969400E-01
Stage1-vs-Stage3
7.236400E-01
Stage1-vs-Stage4
7.512400E-02
Stage2-vs-Stage3
2.465200E-01
Stage2-vs-Stage4
4.532100E-02
Stage3-vs-Stage4
2.576000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.219800E-01
Normal-vs-AfricanAmerican
6.718800E-01
Normal-vs-Asian
6.045800E-01
Caucasian-vs-AfricanAmerican
9.798800E-01
Caucasian-vs-Asian
7.172600E-01
AfricanAmerican-vs-Asian
8.271400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.666000E-01
Normal-vs-Female
5.220000E-01
Male-vs-Female
5.233800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.206800E-01
Normal-vs-Age(41-60Yrs)
2.360000E-01
Normal-vs-Age(61-80Yrs)
7.695600E-01
Normal-vs-Age(81-100Yrs)
8.769200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.664400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.325400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.796800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.001840E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.164390E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.888040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.386000E-01
Normal-vs-Daily Drinker
9.386800E-01
Normal-vs-Weekly Drinker
4.708000E-01
Normal-vs-Occasional Drinker
3.834600E-01
Normal-vs-Social Drinker
1.682390E-01
Non Drinker-vs-Daily Drinker
9.796000E-01
Non Drinker-vs-Weekly Drinker
2.185200E-01
Non Drinker-vs-Occasional Drinker
1.008190E-01
Non Drinker-vs-Social Drinker
5.025600E-02
Daily Drinker-vs-Weekly Drinker
1.868840E-01
Daily Drinker-vs-Occasional Drinker
8.733900E-02
Daily Drinker-vs-Social Drinker
2.965800E-02
Weekly Drinker-vs-Occasional Drinker
7.786800E-01
Weekly Drinker-vs-Social Drinker
5.765800E-01
Occasional Drinker-vs-Social Drinker
8.100200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.579600E-01
Normal-vs-Grade 2
5.583400E-01
Normal-vs-Grade 3
5.678200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.489500E-02
Grade 1-vs-Grade 3
5.668200E-02
Grade 1-vs-Grade 4
2.579600E-01
Grade 2-vs-Grade 3
8.146600E-01
Grade 2-vs-Grade 4
5.583400E-01
Grade 3-vs-Grade 4
5.678200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.924600E-01
Normal-vs-NonDiabetic
4.598800E-01
Diabetic-vs-NonDiabetic
1.906010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.427600E-02
Normal-vs-NoPancreatitis
6.742400E-01
Pancreatitis-vs-NoPancreatitis
1.876390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.340200E-01
Normal-vs-N1
5.701400E-01
N0-vs-N1
5.360800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.053800E-01
Normal-vs-TP53-NonMutant
6.657400E-01
TP53-Mutant-vs-TP53-NonMutant
2.1530999999908E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
